BEAM
Price
$26.45
Change
-$2.13 (-7.45%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
NRIX
Price
$20.27
Change
-$0.91 (-4.30%)
Updated
Dec 18, 04:59 PM (EDT)
56 days until earnings call
Ad is loading...

BEAM vs NRIX

Header iconBEAM vs NRIX Comparison
Open Charts BEAM vs NRIXBanner chart's image
Beam Therapeutics
Price$26.45
Change-$2.13 (-7.45%)
Volume$26.28K
CapitalizationN/A
Nurix Therapeutics
Price$20.27
Change-$0.91 (-4.30%)
Volume$21.12K
CapitalizationN/A
BEAM vs NRIX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. NRIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and NRIX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BEAM: $28.58 vs. NRIX: $21.18)
Brand notoriety: BEAM and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 130% vs. NRIX: 72%
Market capitalization -- BEAM: $2.37B vs. NRIX: $1.5B
BEAM [@Biotechnology] is valued at $2.37B. NRIX’s [@Biotechnology] market capitalization is $1.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • NRIX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -5.36% price change this week, while NRIX (@Biotechnology) price change was -3.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

NRIX is expected to report earnings on Apr 09, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.37B) has a higher market cap than NRIX($1.5B). NRIX YTD gains are higher at: 105.233 vs. BEAM (4.996). BEAM has higher annual earnings (EBITDA): -160.83M vs. NRIX (-177.82M). BEAM has more cash in the bank: 926M vs. NRIX (448M). NRIX has less debt than BEAM: NRIX (27.1M) vs BEAM (162M). BEAM has higher revenues than NRIX: BEAM (350M) vs NRIX (56.4M).
BEAMNRIXBEAM / NRIX
Capitalization2.37B1.5B158%
EBITDA-160.83M-177.82M90%
Gain YTD4.996105.2335%
P/E RatioN/AN/A-
Revenue350M56.4M621%
Total Cash926M448M207%
Total Debt162M27.1M598%
TECHNICAL ANALYSIS
Technical Analysis
BEAMNRIX
RSI
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSISX28.78N/A
N/A
Goldman Sachs International Eq ESG Svc
VBIAX51.17-0.16
-0.31%
Vanguard Balanced Index Adm
JDIAX46.26-0.20
-0.43%
Janus Henderson Overseas A
HUSIX28.74-0.37
-1.27%
Huber Small Cap Value Inv
LMISX25.10-0.97
-3.70%
Franklin U.S. Large Cap Equity IS

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with BEAM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+1.78%
BEAM - NRIX
44%
Loosely correlated
-1.21%
DNLI - NRIX
43%
Loosely correlated
-0.30%
VCYT - NRIX
43%
Loosely correlated
-2.52%
KYMR - NRIX
42%
Loosely correlated
-1.76%
RXRX - NRIX
41%
Loosely correlated
-4.30%
More